Loxiglumide 100 mg | Purity Not Available
TargetMol
Loxiglumide
Search Results
PHT-427 100 mg | Purity Not Available
TargetMol
PHT-427 (CS-0223) is a dual Akt (Ki: 2.7 μM) and PDPK1 (Ki: 5.2 μM) inhibitor (high-affinity binding for the PH domains of Akt and PDPK1).
More Information Supplier PagePHT-427
Sal003 100 mg | 98.58%
TargetMol
Sal003, an effective cell-permeable analog, inhibitis the eIF2α phosphatase.
More Information Supplier PageSal003
Sal003 2 mg | 98.58%
TargetMol
Sal003, an effective cell-permeable analog, inhibitis the eIF2α phosphatase.
More Information Supplier PageSal003
Emapunil 25 mg | 99.80%
TargetMol
Emapunil is an anxiolytic drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO.
More Information Supplier PageEmapunil
Emapunil 2 mg | 99.80%
TargetMol
Emapunil is an anxiolytic drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO.
More Information Supplier PageEmapunil
Fasiglifam 25 mg | Purity Not Available
TargetMol
Fasiglifam (TAK875) is a potent, selective and orally bioavailable GPR40 agonist.
More Information Supplier PageFasiglifam
Tolvaptan 100 mg | 97.00%
TargetMol
Tolvaptan is an orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia.
More Information Supplier PageTolvaptan
Cinaciguat 1 mg | Purity Not Available
TargetMol
Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
More Information Supplier PageCinaciguat
Cinaciguat 25 mg | Purity Not Available
TargetMol
Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
More Information Supplier PageCinaciguat